Memantine and Naltrexone Treatment for Opioid Dependence

NCT00125515 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Opioid Dependence

Interventions

DRUG: Memantine
DRUG: Naltrexone

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]